コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 Critically ill adults requiring continuous renal replacement therapy.
2 r blood flow rate influences circuit life in continuous renal replacement therapy.
3 n of regional citrate anticoagulation during continuous renal replacement therapy.
4 ensity score for the likelihood of receiving continuous renal replacement therapy.
5 blood flow rates of 250 or 150 mL/min during continuous renal replacement therapy.
6 s parameters and then compared with forms of continuous renal replacement therapy.
7 ng adults with acute kidney injury receiving continuous renal replacement therapy.
8 Continuous renal replacement therapy.
9 ation of excess fluid that can be removed by continuous renal replacement therapy.
11 ive mechanical ventilation; 5 (19%) received continuous renal-replacement therapy; 22 (81%) received
13 n anticoagulation has remained a problem for continuous renal replacement therapies and intermittent
14 ations existed between effluent flow rate in continuous renal replacement therapy and extracorporeal
16 e to describe feeding practices in pediatric continuous renal replacement therapy and to evaluate fac
17 ntilation, pulmonary artery catheterization, continuous renal replacement therapy, and permanent card
19 gistry suggests that early intervention with continuous renal replacement therapy, as well as goal-di
21 citrate and calcium anticoagulation prolongs continuous renal replacement therapy circuit life compar
22 mized 212 subjects who were treated with 857 continuous renal replacement therapy circuits (median 2
24 time between RIFLE-I acute kidney injury and continuous renal replacement therapy commencement was 17
25 d Level Replacement Therapy Study (proxy for continuous renal replacement therapy commencement) was t
32 patients with ARF compared with conventional continuous renal replacement therapy (CRRT), a Phase II,
36 of illness, the change in fluid overload at continuous renal replacement therapy discontinuation was
37 inary results to indicate the earlier use of continuous renal replacement therapy for both renal dysf
38 oreal life support and patients initiated on continuous renal replacement therapy for indications oth
42 ith intermittent hemodialysis, initiation of continuous renal replacement therapy in critically ill a
43 verload frequently necessitate initiation of continuous renal replacement therapy in critically ill p
46 ngs suggest a role for earlier initiation of continuous renal replacement therapy in this population,
47 on, extracorporeal membrane oxygenation, and continuous renal replacement therapy, in addition to pla
48 ate an association between fluid overload at continuous renal replacement therapy initiation and mort
49 , severity of illness, and fluid overload at continuous renal replacement therapy initiation found th
50 In pediatric patients, fluid overload at continuous renal replacement therapy initiation is assoc
52 rapy initiation found that fluid overload at continuous renal replacement therapy initiation was the
53 Mean protein and caloric prescriptions at continuous renal replacement therapy initiation were 1.3
54 fter adjusting for percent fluid overload at continuous renal replacement therapy initiation, age, an
55 ze the association between fluid overload at continuous renal replacement therapy initiation, fluid r
59 he possible relevance of biocompatibility in continuous renal replacement therapies is emphasized.
61 in practice to initiate early and high-dose continuous renal replacement therapy led to increased su
62 emodialysis is preferred initially (1D), but continuous renal replacement therapies may be considered
64 onferring greater hemodynamic stability; yet continuous renal replacement therapy may not enhance pat
65 with conventional intermittent hemodialysis, continuous renal replacement therapy may promote kidney
66 this time, center-based results suggest that continuous renal replacement therapy may prove beneficia
67 In patients with sepsis and septic shock, continuous renal replacement therapy offers a means for
68 ermine the effect of timing of initiation of continuous renal replacement therapy on ICU mortality in
70 cular access type, length, site, and mode of continuous renal replacement therapy or international no
71 inclusion criteria and 45 of these received continuous renal replacement therapy prior to transplant
74 r, early data from the prospective pediatric continuous renal replacement therapy registry suggests t
75 ement Therapy Study, earlier commencement of continuous renal replacement therapy relative to RIFLE-I
76 optimal regimen of intermittent dialysis or continuous renal replacement therapy remains to be deter
78 o did not receive a liver transplant, use of continuous renal replacement therapy significantly impro
79 hyperammonemia by 48 hours after initiating continuous renal replacement therapy significantly impro
81 eplacement therapies including hemodialysis, continuous renal replacement therapy, the bioartificial
82 ent therapy initiation, fluid removal during continuous renal replacement therapy, the kinetics of fl
84 en patients on the basis of the intensity of continuous renal replacement therapy; this effect may ha
85 otein and caloric prescription and number of continuous renal replacement therapy treatment days (p <
86 ine whether bacteria could be recovered from continuous renal replacement therapy ultrafiltrates of c
87 rms of length of stay, ventilator usage, and continuous renal replacement therapy usage compared with
91 lower among patients who initially received continuous renal replacement therapy versus intermittent
94 up 4]: >/= 46.0 hr), earlier commencement of continuous renal replacement therapy was not associated
96 with severe acute kidney injury treated with continuous renal replacement therapy, we found no associ
97 mal protein and caloric prescriptions during continuous renal replacement therapy were 2.0 +/- 1.5 g/
98 al protein and caloric prescription while on continuous renal replacement therapy were younger age, i
99 rations in critically ill patients receiving continuous renal replacement therapy, which did not only
100 ty in a large pediatric population receiving continuous renal replacement therapy while on extracorpo
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。